Outcome: Dismissed
JAN212026_07B5203
Our summary
Clinical trials specialist sought NIW for EB-2 to increase ethnic minority participation in drug development. AAO affirmed denial, finding the proposed seven-person business lacked sufficient national importance in healthcare or economy despite furthering a valid national goal of eliminating health disparities.
Official PDF
Official PDF ↗Published by USCIS. The summary is ours, in our own words; the decision text is on uscis.gov.
No criterion in the table was found met in this decision.
What was missing
- Merit and national importance · Proposed clinical trials business lacks demonstrated national health or economic implications at required scale
Criteria
| Criterion | Reading | Why |
|---|---|---|
| Not met | Proposed clinical trials business lacks demonstrated national health or economic implications at required scale | |
| Not reached / not discussed | Not reached because first prong failed | |
| Not reached / not discussed | Not reached because first prong failed |
A published decision describes one case. It is not legal advice and not a prediction for yours.
